You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 84 No. 1, July 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Jamarsan Therapy of Pemphigus Erythematosus

Observations on 2 Patients Treated with Brazilian Regimen

MICHAEL SCHIFF, M.D.

Arch Dermatol. 1961;84(1):103-108.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

At the present time corticosteroids are generally considered the best agents for controlling pemphigus.1 Morbidostasis often necessitates the use of high doses for long periods, causing inevitable dangers inherent in the therapy itself.1,2 The risks of such treatment are fully justified in pemphigus vulgaris, for without corticosteroids a rapid malignant progression almost invariably ensues.3

Pemphigus erythematosus, however, tends to run a relatively slow and benign course4,5 and shows a capricious response to corticosteroids.2,6 In this disease the complications of corticosteroid therapy may outweigh the benefits. Thus, a safe and effective alternative form of management would be highly desirable.

Shortly after the publication of Counter's favorable report7 on the Brazilian treatment of fogo selvagem with Jamarsan, the problem of therapy in 2 patients with typical pemphigus erythematosus arose here. Since there is no apparent clinical or histopathologic difference between pemphigus erythematosus and the "frustre" . . . [Full Text PDF of this Article]


Author Affiliations

HANOVER, N.H.

From the Department of Dermatology, Hitchcock Clinic.

Resident in Dermatology, Hitchcock Clinic (Dr. Schiff).


Footnotes

Submitted for publication Jan. 24, 1961.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.